JBIO
Jade Biosciences
JBIO
JBIO
120 hedge funds and large institutions have $734M invested in Jade Biosciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
8.46% more ownership
Funds ownership: 95.46% → 103.92% (+8.5%)
1% more capital invested
Capital invested by funds: $726M → $734M (+$8.21M)
87% less call options, than puts
Call options by funds: $163K | Put options by funds: $1.23M
Holders
120
Holding in Top 10
6
Calls
$163K
Puts
$1.23M
Top Buyers
| 1 | +$45M | |
| 2 | +$20.3M | |
| 3 | +$11.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.83M |
| 5 |
FCMV
Foresite Capital Management VI
Larkspur,
California
|
+$4.63M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$8.06M | |
| 3 | -$5.01M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$4.58M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.26M |
